{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-072425","form_type":"8-K","ticker":"FENC","cik":"0001211583","company_name":"FENNEC PHARMACEUTICALS INC.","filed_at":"2026-06-10T21:19:17+00:00","discovered_at":"2026-06-10T21:20:00.272055+00:00","generated_at":"2026-06-10T21:20:20.483091+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Fennec shareholders approve all proposals at 2026 annual meeting","bullets":["All five director nominees elected: Islam, Rallis, Brughera, Cook, Hackman with ~20M+ votes each.","Haskell & White LLP ratified as auditor: 26,091,716 for, 134,491 withheld, 29,165 against.","Advisory vote on executive compensation approved: 19,326,750 for, 336,060 against.","Advisory frequency set to every year: 18,235,648 for one year, minimal votes for other intervals.","Amendments to 2020 Equity Incentive Plan and adoption of 2026 Equity Inducement Plan approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-072425","json":"https://secwatch.observer/filing/0001104659-26-072425.json","markdown":"https://secwatch.observer/filing/0001104659-26-072425.md","text":"https://secwatch.observer/filing/0001104659-26-072425.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/0001104659-26-072425-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/tm2617550d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T21:20:20.483091+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2180c70978e6841aa8fc17d4505fb37ae34e38fb","claim":"FENNEC PHARMACEUTICALS INC. shareholders approved Advisory vote on the frequency of advisory votes on compensation at the 2026-06-10 meeting.","evidence_excerpt":"The resolution to vote on the advisory vote on the frequency of advisory votes on compensation of Corporations named executive officers was approved based on the following vote: Votes For Evey One Year 18,235,648 Votes For Evey Two Years 2,326 Votes For Evey Three Years 2,086219 Abstentions 49,294","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/0001104659-26-072425-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-10"}],"fact_type":"shareholder_vote"},{"claim_id":"2566329c780a37a7a83b14112db2c8262c2d5270","claim":"FENNEC PHARMACEUTICALS INC. shareholders approved Ratification and adoption of Fennec's 2026 Equity Inducement Plan at the 2026-06-10 meeting.","evidence_excerpt":"The resolution to ratify and approve the adoption of Fennec’s 2026 Equity Inducement Plan was approved based on the following vote:. Votes For 18,626,207 Votes Against 1,033,779 Abstentions 713,501 Broker Non-Votes 5,881,885","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/0001104659-26-072425-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-10"}],"fact_type":"shareholder_vote"},{"claim_id":"275326d25b02ff0ec68fe25c640e560ffe63c828","claim":"FENNEC PHARMACEUTICALS INC. shareholders approved Election of five nominees to serve as directors at the 2026-06-10 meeting.","evidence_excerpt":"The following five (5) nominees were elected to serve as directors","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/0001104659-26-072425-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-10"}],"fact_type":"shareholder_vote"},{"claim_id":"a590f6f6d1f03e0481e40900fd17c4effebf750e","claim":"FENNEC PHARMACEUTICALS INC. shareholders approved Appointment of Haskell & White LLP as independent public accounting firm and authorization to fix remuneration at the 2026-06-10 meeting.","evidence_excerpt":"The resolution to appoint Haskell & White LLP as independent public accounting firm of the Company and to authorize the Board of Directors to fix their remuneration was approved based on the following vote: Votes For 26,091,716 Votes Withheld 134,491 Votes Against 29,165 Broker Non-Votes 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/0001104659-26-072425-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-10"}],"fact_type":"shareholder_vote"},{"claim_id":"ddafe00e1fd7c6c6fe97a55727f40c3177f694cf","claim":"FENNEC PHARMACEUTICALS INC. shareholders approved Advisory vote on executive compensation at the 2026-06-10 meeting.","evidence_excerpt":"The resolution to vote on the advisory vote on executive compensation was approved based on the following vote: Votes For 19,326,750 Votes Against 336,060 Abstentions 710,677 Broker Non-Votes 5,881,885","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/0001104659-26-072425-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-10"}],"fact_type":"shareholder_vote"},{"claim_id":"fbe36d6576705b7b988d794c0ec868ff3469c1d2","claim":"FENNEC PHARMACEUTICALS INC. shareholders approved Approval of amendments to Corporation's 2020 Equity Incentive Plan at the 2026-06-10 meeting.","evidence_excerpt":"The resolution to approve certain amendments to Corporation’s 2020 Equity Incentive Plan was approved based on the following vote: Votes For (1) 17,425,439 Votes Against 1,429,951 Abstentions 751,944 Broker Non-Votes 5,881,885","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/0001104659-26-072425-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-10"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}